Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people w ...

In the final days of the Biden-Harris Administration, the U.S. Department of Health and Human Services (HHS) last week ...

Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new ...

Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new ...

In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might ...

As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...